- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
July 2nd, 2007
Small-cap bio-nanotech company pSivida (PSDV - Cramer's Take - Stockpickr) took off in the opposite direction after announcing that it entered an agreement for a direct offering to sell its Nasdaq-traded American Depositary Shares and warrants to purchase ADSs, including $6.5 million, to Pfizer (PFE - Cramer's Take - Stockpickr - Rating).
It estimates the net proceeds from the offering will be $16.3 million after the placement agent fees and estimated offering expenses. Shares of pSivida were down 32 cents, or 21%, to $1.20.
|Related News Press|
Arrowhead to Present at Upcoming Conferences October 8th, 2015
Accelerator Corporation Completes $62.8 Million Oversubscribed Financing September 30th, 2015
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
A quantum simulator of impossible physics: In the experiment, developed by the UPV/EHU-University of the Basque Country in conjunction with the University of Tsinghua (China), the atoms simulate absurd actions "as if they were actors in a quantum theatre" October 8th, 2015